Clorox CEO to Step Down for Health Reasons

Dow Jones
05/29

By Nicholas G. Miller

 

Clorox Chief Executive Officer Linda Rendle is stepping down for health reasons after more than 20 years at the company.

The company said it will begin a comprehensive CEO search process, during which time Rendle will remain at the helm of the company.

Rendle first joined the company in 2003 as a senior sales analyst, rising through the ranks until becoming CEO in 2020.

"I believe now is the right time to begin working toward a leadership transition so I can focus more fully on my health and family once a successor is appointed," said Rendle, who is also board chair.

Before joining Clorox, Rendle worked for Procter & Gamble, where she held several positions in sales management. She graduated from Harvard in 2000.

Rendle "has helped make the company stronger, more agile and better positioned for the future," said Matthew Shattock, lead independent director of the board. "Linda has modernized our digital and operational foundation, sharpened the portfolio toward faster-growing health and hygiene categories, and accelerated innovation while continuing to invest in our brands, people and growth."

Last month, Clorox cut its full-year earnings guidance, citing the impact of transaction costs from acquiring Purell-maker Gojo, coupled with long-term investments.

 

Write to Nicholas G. Miller at nicholas.miller@wsj.com.

 

(END) Dow Jones Newswires

May 28, 2026 16:07 ET (20:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10